Moderate

Cerebral palsy

neurology · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

A permanent disorder of movement and posture due to a non-progressive lesion of the developing brain, with varied motor patterns and common comorbidities. Management is multidisciplinary, aiming to optimise function and prevent secondary problems.

Red flags

  • Loss of acquired skills (regression) suggesting a progressive disorder, not CP
  • Rapidly worsening tone or new focal neurology
  • Hip pain or signs of hip subluxation/dislocation
  • Aspiration, recurrent chest infections or faltering growth

Assessment

Differential diagnosis

  • Cerebral palsy (spastic, dyskinetic, ataxic or mixed)
  • Progressive neurodegenerative/metabolic disorder (regression excludes CP)
  • Spinal cord lesion
  • Hereditary spastic paraplegia
  • Neuromuscular disorder (e.g. muscular dystrophy)
  • Dopa-responsive dystonia (treatable mimic)
  • Global developmental delay from other cause

Investigations

  • Developmental and birth history; motor pattern and tone assessment
  • MRI brain to define the lesion and support aetiology
  • Exclude progressive/metabolic disorders if atypical or regressing
  • Hearing and vision assessment
  • Assess feeding/swallow, growth, and respiratory status
  • Hip surveillance imaging and bone health assessment

Management

  • Recognise early motor signs (abnormal tone, asymmetry, delayed milestones, persistent primitive reflexes)
  • Confirm the disorder is non-progressive; investigate regression as it excludes CP
  • Obtain MRI and exclude treatable mimics (e.g. dopa-responsive dystonia)
  • Classify motor type and functional level (e.g. GMFCS)
  • Refer to a multidisciplinary child development team
  • Manage spasticity with physiotherapy, orthoses, botulinum toxin and oral agents
  • Institute hip surveillance to detect and prevent dislocation
  • Optimise nutrition, communication, and treat comorbidities (epilepsy, reflux, constipation, pain)
  • Support education, equipment, and family; plan transition to adult services

Drugs & doses

Baclofen PO (oral antispasticity), titrated by weight/response; intrathecal in severe cases
Botulinum toxin A intramuscular injections for focal spasticity (specialist)
Diazepam or tizanidine as adjuncts for spasticity/spasms
Treat comorbidities: anti-epileptics, laxatives (macrogol), reflux therapy as needed

Disposition

Community child development team with multidisciplinary follow-up; specialist referral for spasticity management, hip surveillance, and comorbidities.

Complications & pitfalls

  • Hip subluxation/dislocation and scoliosis
  • Feeding difficulty, aspiration and malnutrition
  • Epilepsy, communication and learning difficulties
  • Chronic pain, constipation and reduced bone density

Exam pearls

  • Cerebral palsy is non-progressive; any regression demands a search for another diagnosis
  • Always consider dopa-responsive dystonia, a treatable mimic
  • Structured hip surveillance prevents painful dislocation
  • Function, not the MRI, drives management goals; use a multidisciplinary approach

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.